Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …
MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - The Lancet, 2021 - thelancet.com
Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …
MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - Lancet, 2021 - pure.au.dk
BACKGROUND: The optimal revascularisation strategy for patients with left main coronary
artery disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients …
artery disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients …
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …
MS Sabatine, BA Bergmark, SA Murphy… - Lancet (London …, 2021 - europepmc.org
Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
[引用][C] Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient …
MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - The Lancet, 2021 - cir.nii.ac.jp
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass
grafting in left main coronary artery disease: an individual patient data meta-analysis | CiNii …
grafting in left main coronary artery disease: an individual patient data meta-analysis | CiNii …
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …
MS Sabatine, BA Bergmark… - Lancet (London …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …
MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - The Lancet, 2021 - Elsevier
Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …
MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - The Lancet, 2021 - Elsevier
Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …